AIM ImmunoTech Total Non Current Liabilities 2011-2026 | AIM

Annual Total Non Current Liabilities AIM ImmunoTech

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
-	-	-	-	-	-	6.18 M	3.38 M	2.8 M	940 K	-	-	37 K	350 K	479 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
6.18 M	37 K	2.02 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Arcturus Therapeutics Holdings ARCT	30.4 M	$ 7.15	1.64 %	$ 196 M	Israel
FSD Pharma HUGE	79.1 K	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	158 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	189 M	$ 1.69	4.66 %	$ 198 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
BioNTech SE BNTX	622 M	$ 92.82	0.74 %	$ 22.4 B	Germany
AstraZeneca PLC AZN	34.7 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	7.32 M	-	0.74 %	$ 768 M	Israel
Compugen Ltd. CGEN	31.3 M	$ 2.72	-2.86 %	$ 254 M	Israel
Abcam plc ABCM	128 M	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	64 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	645 K	-	-18.52 %	$ 27.3 M	Britain
Enlivex Therapeutics Ltd. ENLV	383 M	$ 0.67	-6.24 %	$ 30.6 M	Israel
Esperion Therapeutics ESPR	355 M	$ 3.13	-0.16 %	$ 651 M	USA
Eton Pharmaceuticals ETON	4.56 M	$ 31.47	-3.44 %	$ 847 M	USA
Affimed N.V. AFMD	13.4 M	-	-34.95 %	$ 21.5 M	Germany
Forte Biosciences FBRX	10.5 M	$ 21.98	1.81 %	$ 285 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Celyad Oncology SA CYAD	4.97 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	132 M	-	-	$ 344 M	USA
IMV IMV	8.95 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Grifols, S.A. GRFS	10.6 B	$ 8.03	0.56 %	$ 5.46 B	Spain
Ayala Pharmaceuticals AYLA	497 K	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	14.6 M	$ 0.87	1.11 %	$ 145 M	USA
Cyclacel Pharmaceuticals CYCCP	1.06 M	-	-4.36 %	$ 27 M	USA
Gracell Biotechnologies GRCL	51.9 M	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	26.1 M	$ 14.63	-1.68 %	$ 210 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
InflaRx N.V. IFRX	678 K	$ 2.76	5.75 %	$ 186 M	Germany
Aeterna Zentaris AEZS	14 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 3.49	2.65 %	$ 5.75 M	Israel
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA